Management of infections in immunocompromised cancer patients
Bajetta, E.; Gasparini, G.; Monfardini, S.; Volonterio, A.; Buzzoni, R.; Shinde, S.
Haematologica 69(5): 576-597
1984
ISSN/ISBN: 0390-6078 PMID: 6437936 Document Number: 227220
Document emailed within 1 workday
Related Documents
Saral, R. 1988: Management of mucocutaneous herpes simplex virus infections in immunocompromised patients American Journal of Medicine 85(2a): 57-60Balfour, H.H. 1988: Varicella zoster virus infections in immunocompromised hosts. a review of the natural history and management American Journal of Medicine 85(2a): 68-73
Kalugina, M.I.; Karazhas, N.V.; Kozina, V.I.; Balabanova, R.M.; Ermakova, T.M.; Rybalkina, T.N. 2009: Herpesvirus infections in immunocompromised patients Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1: 79-80
Pachón, J.; Capote, F.; Verano, A.; Cuello, J.A. 1989: Pulmonary infections in immunocompromised patients Enfermedades Infecciosas y Microbiologia Clinica 7(Suppl 1): 23-33
Schwenke, H. 1992: Fungal infections in granulocytopenic and immunocompromised patients Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(9): 422-437
Meynard, J.L. 1997: Prevention of atypical mycobacterium infections in immunocompromised patients Annales de Medecine Interne 148(3): 230-234
Schubert, M.M. 1991: Oral manifestations of viral infections in immunocompromised patients Current Opinion in Dentistry 1(4): 384-397
Borkowsky, W. 1984: Viral infections in immunocompromised children Pediatric Annals 13(9): 682
Wasak-Szulkowska, E. 2005: Candida infections in immunocompromised hosts Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(109): 5-9
Brennan, P.J.; DeGirolamo, M.P. 1991: Musculoskeletal infections in immunocompromised hosts Orthopedic Clinics of North America 22(3): 389-399
Prommalikit, O.; Pengsaa, K.; Thisyakorn, U. 2010: Pneumococcal infections in high-risk and immunocompromised hosts Journal of the Medical Association of Thailand 93(Suppl 5): S61-S70
Feldman, S. 1986: Varicella zoster infections of the fetus, neonate, and immunocompromised child Advances in Pediatric Infectious Diseases 1: 99-115
Antonios, S.N.; Tolba, O.A.; Othman, A.A.; Saad, M.A. 2010: A preliminary study on the prevalence of parasitic infections in immunocompromised children Journal of the Egyptian Society of Parasitology 40(3): 617-630
Ramírez Palacios, R.M.; Sánchez, J.; Bermúdez, R.H.; Ramírez Ronda, C.H. 1986: Varicella and herpes zoster infections in immunocompromised host: prevention and treatment Boletin de la Asociacion Medica de Puerto Rico 78(4): 142-145
Seth, A.K. 2006: Management of hepatitis C in HIV infected and other immunocompromised individuals Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 27(3): 111-117
Contini, C. 2008: Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient Parassitologia 50(1-2): 45-50
Mahmood, M.A.; Saniotis, A. 2011: Use of syndromic management algorithm for sexually transmitted infections and reproductive tract infections management in community settings in Karachi JPMA. Journal of the Pakistan Medical Association 61(5): 453-457
Furukawa, T.; Uji, T.; Miyake, Y.; Hyodo, A.; Deguchi, K. 1993: Therapeutic efficacy of cefodizime in combination with aminoglycosides against systemic infections caused by Pseudomonas aeruginosa in immunocompromised tumour bearing mice Japanese Journal of Antibiotics 46(6): 472-481
Collins, B.; Smith, C.; Anderson, M.; Garrana, S.; Allen, P.; Vasan, N.R. 2015: Head and neck skin cancer in the immunocompromised patient: a quantitative analysis Journal of the Oklahoma State Medical Association 108(1): 8-12
Sarafannikova, G.A. 1978: Management of patients with Pseudomonas aeruginosa infections Meditsinskaia Sestra 37(4): 29-32